Invention Grant
US07842805B2 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof
失效
药物化合物作为胱天蛋白酶的活化剂和凋亡诱导剂及其用途
- Patent Title: Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof
- Patent Title (中): 药物化合物作为胱天蛋白酶的活化剂和凋亡诱导剂及其用途
-
Application No.: US11773293Application Date: 2007-07-03
-
Publication No.: US07842805B2Publication Date: 2010-11-30
- Inventor: Sui Xiong Cai , Mark B. Anderson , Adam Willardsen , Songchun Jiang , Robert J. Halter , Rachel Slade , Yevgeniya Klimova
- Applicant: Sui Xiong Cai , Mark B. Anderson , Adam Willardsen , Songchun Jiang , Robert J. Halter , Rachel Slade , Yevgeniya Klimova
- Applicant Address: US UT Salt Lake City US NY Tarrytown
- Assignee: Myrexis, Inc.,EpiCept Corporation
- Current Assignee: Myrexis, Inc.,EpiCept Corporation
- Current Assignee Address: US UT Salt Lake City US NY Tarrytown
- Agency: I.P. Group; Myrexis, Inc.
- Agent Kelly A. Echols; Herbert L. Ley, III
- Main IPC: C07D403/12
- IPC: C07D403/12 ; C07D253/08 ; A61K31/53 ; A61P35/00
Abstract:
Disclosed are 1-arylamino-phthalazines, 4-arylamino-benzo[d][1,2,3]triazines, and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
Public/Granted literature
- US20080020985A1 PHARMACEUTICAL COMPOUNDS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF Public/Granted day:2008-01-24
Information query
